129 related articles for article (PubMed ID: 2003341)
21. Prevalence and risk factors for trimethoprim-sulfamethoxazole-resistant Escherichia coli among women with acute uncomplicated urinary tract infection in a developing country.
Gangcuangco LM; Alejandria M; Henson KE; Alfaraz L; Ata RM; Lopez M; Saniel M
Int J Infect Dis; 2015 May; 34():55-60. PubMed ID: 25748571
[TBL] [Abstract][Full Text] [Related]
22. Single-dose therapy with trimethoprim-sulfamethoxazole for urinary tract infection in women.
Tolkoff-Rubin NE; Weber D; Fang LS; Kelly M; Wilkinson R; Rubin RH
Rev Infect Dis; 1982; 4(2):444-8. PubMed ID: 6981162
[TBL] [Abstract][Full Text] [Related]
23. Ceftibuten versus trimethoprim-sulfamethoxazole for oral treatment of febrile urinary tract infection in children.
Mårild S; Jodal U; Sandberg T
Pediatr Nephrol; 2009 Mar; 24(3):521-6. PubMed ID: 18818954
[TBL] [Abstract][Full Text] [Related]
24. Resistance Patterns of Escherichia coli in Women with Uncomplicated Urinary Tract Infection Do Not Correlate with Emergency Department Antibiogram.
Hines MC; Al-Salamah T; Heil EL; Mallemat H; Witting MD; Johnson JK; Winters ME; Hayes BD
J Emerg Med; 2015 Dec; 49(6):998-1003. PubMed ID: 26281821
[TBL] [Abstract][Full Text] [Related]
25. Treatment of recurrent urinary tract infection with norfloxacin versus trimethoprim-sulfamethoxazole.
Seidmon EJ; Krisch EB; Truant AL; Amy BG; Childs SJ; Hurst AT; McCabe RE
Urology; 1990 Feb; 35(2):187-93. PubMed ID: 2407023
[TBL] [Abstract][Full Text] [Related]
26. Clinical experience with ofloxacin in urinary tract infection.
Cox CE; Callery SV; Tack KJ
Infection; 1986; 14 Suppl 4():S303-4. PubMed ID: 3546150
[TBL] [Abstract][Full Text] [Related]
27. Ciprofloxacin versus trimethoprim-sulfamethoxazole: treatment of community-acquired urinary tract infections in a prospective, controlled, double-blind comparison.
Grubbs NC; Schultz HJ; Henry NK; Ilstrup DM; Muller SM; Wilson WR
Mayo Clin Proc; 1992 Dec; 67(12):1163-8. PubMed ID: 1469927
[TBL] [Abstract][Full Text] [Related]
28. Physician adherence to recommendations for duration of empiric antibiotic treatment for uncomplicated urinary tract infection in women: a national drug utilization analysis.
Kahan NR; Chinitz DP; Kahan E
Pharmacoepidemiol Drug Saf; 2004 Apr; 13(4):239-42. PubMed ID: 15255090
[TBL] [Abstract][Full Text] [Related]
29. Ofloxacin versus trimethoprim and co-trimoxazole in the treatment of uncomplicated urinary tract infection in general practice.
Spencer RC; Cole TP
Br J Clin Pract; 1992; 46(1):30-3. PubMed ID: 1419551
[TBL] [Abstract][Full Text] [Related]
30. [Single-dose amoxicillin, TMP-SMX and ofloxacin therapy in lower urinary tract infections].
Unal S; Aydin M; Ozaydin N; Akin A
Mikrobiyol Bul; 1989 Jul; 23(3):231-7. PubMed ID: 2487463
[TBL] [Abstract][Full Text] [Related]
31. Pharmacodynamic evaluation of ofloxacin and trimethoprim-sulfamethoxazole in vaginal fluid of women treated for acute cystitis.
Tartaglione TA; Johnson CR; Brust P; Opheim K; Hooton TM; Stamm WE
Antimicrob Agents Chemother; 1988 Nov; 32(11):1640-3. PubMed ID: 3075434
[TBL] [Abstract][Full Text] [Related]
32. Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens.
Raz R; Chazan B; Kennes Y; Colodner R; Rottensterich E; Dan M; Lavi I; Stamm W;
Clin Infect Dis; 2002 May; 34(9):1165-9. PubMed ID: 11941541
[TBL] [Abstract][Full Text] [Related]
33. Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections.
Gupta K; Hooton TM; Stamm WE
Ann Intern Med; 2001 Jul; 135(1):41-50. PubMed ID: 11434731
[TBL] [Abstract][Full Text] [Related]
34. Spectrum and susceptibility of pathogens causing acute uncomplicated lower UTI in females and its correlation to bacteriologic outcome after single dose therapy with fosfomycin trometamol versus ofloxacin/co-trimoxazole.
Naber KG; Thyroff-Friesinger U
Infection; 1992; 20 Suppl 4():S296-301. PubMed ID: 1294521
[TBL] [Abstract][Full Text] [Related]
35. Diagnosis and treatment of urinary tract infections across age groups.
Chu CM; Lowder JL
Am J Obstet Gynecol; 2018 Jul; 219(1):40-51. PubMed ID: 29305250
[TBL] [Abstract][Full Text] [Related]
36. Ofloxacin in the management of complicated urinary tract infections, including prostatitis.
Cox CE
Am J Med; 1989 Dec; 87(6C):61S-68S. PubMed ID: 2690622
[TBL] [Abstract][Full Text] [Related]
37. A Seven-Day Course of TMP-SMX May Be as Effective as a Seven-Day Course of Ciprofloxacin for the Treatment of Pyelonephritis.
Fox MT; Melia MT; Same RG; Conley AT; Tamma PD
Am J Med; 2017 Jul; 130(7):842-845. PubMed ID: 28216442
[TBL] [Abstract][Full Text] [Related]
38. Double-blind study comparing 3-day regimens of cefixime and ofloxacin in treatment of uncomplicated urinary tract infections in women.
Raz R; Rottensterich E; Leshem Y; Tabenkin H
Antimicrob Agents Chemother; 1994 May; 38(5):1176-7. PubMed ID: 8067759
[TBL] [Abstract][Full Text] [Related]
39. Antibiotic prophylaxis for transrectal biopsy of the prostate: a prospective randomized study of the prophylactic use of single dose oral fluoroquinolone versus trimethoprim-sulfamethoxazole.
Isen K; Küpeli B; Sinik Z; Sözen S; Bozkirli I
Int Urol Nephrol; 1999; 31(4):491-5. PubMed ID: 10668944
[TBL] [Abstract][Full Text] [Related]
40. Ofloxacin vs. cotrimoxazole in patients with complicated urinary tract infections.
Vellucci A; Bernardini G; Battaglia AM; Battaglia P
Int J Clin Pharmacol Ther Toxicol; 1987 May; 25(5):279-81. PubMed ID: 3496284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
